While at dinner with some friends who are doctors and other healthcare workers, a discussion of comments made by President Obama in his 2016 State of the Union with respect to cancer research came up. My friends and colleagues were excited by the possibility of diminishing data “siloing”. This is what the President had to […]
As noted in our very first post about clinical trials for Fragile X Syndrome: “The intention here is to take a slightly different perspective. First, it is interesting to note that in many articles describing the results of clinical trials, the repeated positive results of drug tests in “Fragile X” (FX) animal models are cited […]
The following video is shared from the FRAXA Research Foundation, whose research director, Dr. Michael Tranfaglia, M.D., gave a talk at the April 21, 2015 Stanford University Intellectual and Developmental Disability Center (IDD-C) research symposium. Dr. Tranfaglia provided both a review of the bases for recent clinical trials as well as various avenues for future […]